A FcγRIII-engaging bispecific antibody expands the range of HER2-expressing breast tumors eligible to antibody therapy
Marc Turini(Inserm), Brigitte Kerfélec(Inserm)
Cited by 46
Related Papers
No related papers found
Powered by citation graph analysis